{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "mesh:D002470",
      "entity_text" : "cell viability",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01387",
      "entity_text" : "SRT-1720",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "By contrast, the SIRT1 activator, SRT-1720, reduced cell viability compared to ioxitalamate treatment (p < 0.001, as shown by one-way ANOVA, n = 3 experiments), particularly at a high concentration (p = 0.002 and 0.00002 at 2,500 and 5,000 nM, respectively) (XREF_FIG).",
  "reading_complete" : "2020-08-02T14:00:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:59:25Z",
  "trigger" : "reduced",
  "evidence" : [ "SRT-1720, reduced cell viability" ],
  "pmc_id" : "4687441",
  "score" : 0
}